Kindly MD, Inc. (KDLY)
NASDAQ: KDLY · Real-Time Price · USD
1.900
-0.180 (-8.65%)
At close: Mar 28, 2025, 4:00 PM
1.850
-0.050 (-2.63%)
After-hours: Mar 28, 2025, 7:55 PM EDT
Kindly MD Revenue
Kindly MD had revenue of $647.87K in the quarter ending September 30, 2024, a decrease of -25.47%. This brings the company's revenue in the last twelve months to $2.88M, down -27.01% year-over-year. In the year 2023, Kindly MD had annual revenue of $3.77M, down -0.49%.
Revenue (ttm)
$2.88M
Revenue Growth
-27.01%
P/S Ratio
3.77
Revenue / Employee
$41,844
Employees
65
Market Cap
11.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.77M | -18.48K | -0.49% |
Dec 31, 2022 | 3.79M | 1.28M | 51.22% |
Dec 31, 2021 | 2.50M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKDLY News
- 2 months ago - KindlyMD(R) Opens New Integrated Behavioral Health Clinic on the Ogden Regional Medical Center Campus - Accesswire
- 4 months ago - KindlyMD(R) Announces Third Quarter 2024 Financial Results - Accesswire
- 5 months ago - KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility - Accesswire
- 7 months ago - KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024 - Accesswire
- 7 months ago - KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director - Accesswire
- 8 months ago - KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update - Accesswire
- 8 months ago - KindlyMD to Present at Upcoming August 2024 Investor Conferences - Accesswire
- 8 months ago - KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling - Accesswire